Respiratory syncytial virus infection in elderly adults

Drugs and Aging

Volumn 22, Issue 7, 2005, Pages 577-587

  Falsey, Ann R ^a   Walsh, Edward E ^b  

^a ROCHESTER GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; RESPIRATORY SYNCYTIAL VIRUS VACCINE; SUBUNIT VACCINE;

ANTIBODY TITER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ELECTROIMMUNOASSAY; GERIATRIC PATIENT; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFLUENZA; LUNG INFILTRATE; NURSING HOME; PRIORITY JOURNAL; PROTEIN PURIFICATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; THORAX RADIOGRAPHY; VIRUS DIAGNOSIS; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS LOAD;

AGED; AGED, 80 AND OVER; HOMES FOR THE AGED; HUMANS; LONG-TERM CARE; NURSING HOMES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VACCINATION;

EID: 24044538547     PISSN: 1170229X     EISSN: 1170229X     Source Type: Journal    
DOI: 10.2165/00002512-200522070-00004     Document Type: Review

References (117)

1. Collins P. The molecular biology of human respiratory syncytial viruses (RSV) of the genus Pneumovirus. In: Kingsbury DW, editor. The Paramyxoviruses. New York: Plenum Publishing, 1991: 103-62
2. Anderson LJ, Hierholzer JC, Tsou C, et al. Antigenic characterizaton of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 1985; 151: 626-33
3. Hendry RM, Talis AL, Godfrey E, et al. Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis 1986; 153: 291-7
4. Hendry RM, Fernie BF, Anderson LJ, et al. Antigenic and epidemiologic analysis of distinct strains of respiratory syncytial virus from two successive community outbreaks [1983-85]. In: Mahy B, Kolakofsky D, editors. Biology of negative strand viruses. Amsterdam: Elsevier Science Publishers BV, 1987: 397-403
5. van den Hoogen BG, De Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719-24
6. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-86
7. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 334: 1917-28
8. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13: 371-84
9. Englund JA, Sullivan CJ, Jordan MC, et al. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 1988; 109: 203-8
10. Falsey AR, Formica MA, Treanor JJ, et al. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol 2003; 41: 4160-5
11. Hall CB, Geiman JM, Biggar R, et al. Respiratory syncytial virus infections within families. N Engl J Med 1976; 294: 414-9
12. Casiano-Colon AE, Hulbert BB, Mayer TK, et al. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial infection in adults. J Clin Virol 2003; 28: 169-74
13. Agius G, Dindinaud G, Biggar RJ, et al. An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings. J Med Virol 1990; 30: 117-27
14. Arroyo JC, Jordan W, Milligan L. Upper respiratory tract infection and serum antibody responses in nursing home patients. Am J Infect Control 1988; 16: 152-8
15. Center for Disease Control. Epidemiologic notes and reports. Respiratory syncytial virus: Missouri. MMWR Morb Mortal Wkly Rep 1977; 26: 351
16. Falsey AR, Walsh EE, Betts RF. Serologic evidence of respiratory syncytial virus infection in nursing home patients. J Infect Dis 1990; 162: 568-9
17. Falsey AR, Treanor JJ, Betts RF, et al. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc 1992; 40: 115-9
18. Garvie DG, Gray J. Outbreak of respiratory syncytial virus infection in the elderly. BMJ 1980; 281: 1253-4
19. Gross PA, Rodstein M, LaMontagne JR, et al. Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home. Arch Intern Med 1988; 148: 559-61
20. Hart RJC. An outbreak of respiratory syncytial virus infection in an old people's home. J Infect 1984; 8: 259-61
21. Hornsleth A, Siggaard-Andersen J, Hjort L. Epidemiology of herpesvirus and respiratory virus infections. Part 1: serologic findings. Geriatrics 1975; 30: 61-8
22. Mandal SK, Joglekar VM, Khan AS. An outbreak of respiratory syncytial virus infection in a continuing-care geriatric ward. Age Ageing 1985; 14: 184-6
23. Mathur U, Bentley DW, Hall CB. Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill. Ann Intern Med 1980; 93: 49-52
24. Morales F, Calder MA, Inglis JM, et al. A study of respiratory infection in the elderly to assess the role of respiratory syncytial virus. J Infect 1983; 7: 236-47
25. Nicholson KG, Baker DJ, Farquhar A, et al. Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly. Epidemiol Infect 1990; 105: 609-18
26. Orr PH, Peeling RW, Fast M, et al. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. Clin Infect Dis 1996; 23: 1240-5
27. Osterweil D, Norman D. An outbreak of an influenza-like illness in a nursing home. J Am Geriatr Soc 1990; 38: 659-62
28. Public Health Laboratory Service Communicable Diseases Surveillance Centre. Respiratory syncytial virus infection in the elderly 1976-1982. BMJ 1983; 287: 1618-9
29. Sorvillo FJ, Huie SF, Strassburg MA, et al. An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly. J Infect 1984; 9: 252-6
30. Wald TG, Miller BA, Shult P, et al. Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons? J Am Geriatr Soc 1995; 43: 170-4
31. Ellis SE, Coffey CS, Mitchel Jr EF, et al. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc 2003; 51: 761-7
32. Falsey AR, McCann RM, Hall WJ, et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc 1995; 43: 30-6
33. Fransen H, Heigl Z, Wolontis S, et al. Infections with viruses in patients hospitalized with acute respiratory illness, Stockholm 1963-1967. Scand J Infect Dis 1969; 1: 127-36
34. Vikerfors T, Grandien M, Olcen P. Respiratory syncytial virus infections in adults. Am Rev Respir Dis 1987; 136: 561-4
35. Falsey AR, Cunningham CK, Barker WH, et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995; 172: 389-94
36. Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial virus and other infections in persons with chronic cardinity. opulmonary disease. Am J Respir Crit Care Med 1999; 160: 791-5
37. Dowell SF, Anderson LJ, Gary Jr HE, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996; 174: 456-62
38. Glezen WP, Greenberg SB, Atmar RL, et al. Impact of respiraza tory virus infections on persons with chronic underlying conditions. JAMA 2000; 283: 499-505
39. Nicholson KG, Kent J, Hammersley V, et al. Acute viral infections of upper respiratory tract in elderly people living in the community; comparative, prospective, population based study of disease burden. BMJ 1997; 315: 1060-4
40. Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly adults. J Infect Dis 2004; 189: 233-8
41. Zambon MC, Stockton JD, Clewley JP, et al. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358: 1410-6
42. Buscho RO, Saxtan D, Shultz PS, et al. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 1978; 137: 377-83
43. Carilli AP, Gohd R, Gordon W. A virologic study of chronic bronchitis. N Engl J Med 1964; 170: 123-7
44. Fagon JY, Chastre J. Severe exacerbations of COPD patients: the role of pulmonary infections. Semin Respir Infect 1996; 11: 109-18
45. Gump DW, Phillips CA, Forsyth BR. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976; 113: 465-74
46. Lambert HP, Stern H. Infective factors in exacerbations of bronchitis and asthma. BMJ 1972; 3: 323-7
47. Lamy ME, Pouthier-Simon F, Debacker-Willame E. Respiratory viral infections in hospital patients with chronic bronchitis: observations during periods of exacerbation and quiescence. Chest 1973; 63: 336-41
48. Smith CB, Golden CA, Kanner RE, et al. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980; 121: 225-32
49. Sommerville RG. Respiratory syncytial virus in acute exacerbations of chronic bronchitis. Lancet 1963; II: 1247-8
50. Stenhouse AC. Viral antibody levels and clinical status in acute exacerbations of chronic bronchitis: a controlled prospective study. BMJ 1968; 3: 287-90
51. Wiselka MJ, Kent J, Cookson JB, et al. Impact of respiratory infection in patients with chronic chest disease. Epidemiol Infect 1993; 111: 337-46
52. Borg I, Rohde G, Loseke S, et al. Evaluation of quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases. Eur Respir J 2003; 21: 944-51
53. Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003; 58: 37-42
54. Seemungal TAR, Wedzicha JA. Viral infections in obstructive airway diseases. Curr Opin Pulm Med 2003; 9: 111-6
55. Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618-23
56. Schwarze J, O'Donnell DR, Rohwedder A, et al. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004; 169: 801-5
57. Fleming DM, Cross KW. Respiratory syncytial virus or influenza? Lancet 1993; 342: 1507-10
58. Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect 1996; 116: 51-63
59. Griffin M, Coffey CS, Neuzil KM, et al. Winter viruses: influenza and respiratory syncytial virus-related morbidity in chronic lung disease. Arch Intern Med 2003; 162: 1229-36
60. Murphy D, Rose RC. Letters: respiratory syncytial viral pneumonia in a human immunodeficiency virus-infected man. JAMA 1989; 261: 1147
61. Sriskandan S, Shaunak S. Correspondence: respiratory syncytial infection in an adult with AIDS. Clin Infect Dis 1993; 17: 1065
62. Falsey AR. Respiratory syncytial virus infection in older persons. Vaccine 1998; 16: 1775-8
63. Falsey AR, Erdman D, Anderson LJ, et al. Human metapneumovirus infections in young and elderly adults. J Infect Dis 2003; 187: 785-90
64. Englund JA, Piedra P, Jewell A, et al. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol 1996; 34: 1649-53
65. Falsey AR, McCann RM, Hall WJ, et al. Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults. J Am Geriatr Soc 1996; 44: 71-3
66. Falsey AR, Formica MA, Walsh EE. Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. J Clin Microbiol 2002; 40: 817-20
67. Kimball AM, Foy HM, Cooney MK, et al. Isolation of respiratory syncytial and influenza viruses from the sputum of patients hospitalized with pneumonia. J Infect Dis 1983; 147: 181-4
68. Simpson JL, Moric I, Wark P, et al. Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic methods. J Clin Virol 2003; 26: 339-46
69. Hall CB, Douglas RG, Geiman JM. Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr 1976; 131: 1-5
70. Hall CB, Douglas RG, Geiman JM, et al. Nosocomial respiratory syncytial virus infections. N Engl J Med 1975; 293: 1343-6
71. Kellogg JA. Culture vs direct antigen assays for detection of microbial pathogens from lower respiratory tract specimens suspected of containing the respiratory syncytial virus. Arch Pathol Lab Med 1991; 115: 451-8
72. Freymuth F, Vabret A, Gouarin S, et al. Epidemiology and diagnosis of respiratory syncytial virus in adults. Rev Mal Respir 2004; 21: 13-4
73. Henkel JH, Aberle SW, Kundi M, et al. Improved detection of respiratory syncytial virus in nasal aspirates by seminested RT-PCR. J Med Virol 1997; 53: 366-71
74. van Milaan AJ, Sprenger MJW, Rothbarth PH, et al. Detection of respiratory syncytial virus by RNA-polymerase chain reaction and differentiation of subgroups with oligonucleotide probes. J Med Virol 1994; 44: 80-7
75. Fan J, Henrickson KJ, Savatski LL. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription: polymerase chain reaction-enzyme hybridization [hextreatment aplex] assay. Clin Infect Dis 1998; 26: 1-6
76. Stockton J, Ellis JS, Saville M, et al. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J Clin Microbiol 1998; 36: 2990-5
77. Falsey AR, Criddle MC, Walsh EE. Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness. J Clin Virol. In press
78. Ostlund MR, Wirgart BZ, Linde A, et al. Respiratory virus infections in Stockholm during seven seasons: a retrospective study of laboratory diagnosis. Scand J Infect Dis 2004; 36: 460-5
79. Marrie TJ, Falsey AR, Campbell NN, et al. The complement fixation test is not sensitive for the diagnosis of respiratory syncytial virus in patients with community acquired pneumonia (CAP) [abstract]. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; 2001 Dec 16-19; Chicago (IL)
80. Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352 (17): 1749-59
81. Walsh EE, Falsey AR. Age related differences in humoral immune response to respiratory syncytial virus infection in adults. J Med Virol 2004; 73: 295-9
82. Erdman D, Anderson LJ. Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G [IgG], IgA, and IgM antibodies to respiratory syncytial virus. J Clin Microbiol 1990; 28: 2744-9
83. Vikerfors T, Grandien M, Johansson M, et al. Detection of an immunoglobulin M response in the elderly for early diagnosis of respiratory syncytial virus infection. J Clin Microbiol 1988; 26: 808-11
84. Zaroukian MH, Leader I. Community-acquired pneumonia and infection with respiratory syncytial virus. Ann Intern Med 1988; 109: 515-6
85. Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 1995; 21: 376-9
86. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778-82
87. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 1997; 102: 10-8
88. Committee on Infectious Diseases. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 1993; 92: 501-4
89. Committee on Infectious Diseases. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 1996; 97: 137-40
90. Cianci C, Kuo-long Y, Combrink K, et al. Orally active fusion inhibitor of respiratory syncytial virus. Antimicrob Agents Chemother 2004; 48: 413-22
91. Gazumyan A, Mitsner B, Ellestad GA. Novel anti-RSV dianionic dendrimer-like compounds: Synthesis and Biological Evaluation. Curr Pharm Des 2000; 6: 525-46
92. Maggon K, Barik S. New drugs and treatment for respiratory syncytial virus. Rev Med Virol 2004; 14: 149-68
93. Hall CB, McBride JT, Gala CL, et al. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA 1985; 254: 3047-51
94. Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. N Engl J Med 1983; 308: 1443-7
95. Rodriguez WJ, Arrobio J, Fink R, et al. Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Arch Pediatr Adolesc Med 1999; 153: 469-74
96. Groothuis JR, Simoes EAF, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993; 329: 1524-30
97. Groothuis JR, Simoes EAF, Hemming VG, et al. Respiratory syncytial virus [RSV] infection in preterm infants and the protective effects of RSV immune globulin [RSVIG]. Pediatrics 1995; 95: 463-7
98. Rodriguez WJ, Gruber WC, Welliver RC, et al. Respiratory syncytial virus [RSV] immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics 1997; 99: 472-5
99. Sorrentino M, Powers T. Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. Palivizumab Outcomes Study Group. Pediatr Infect Dis J 2000; 19: 1068-71
100. Englund JA, Piedra PA, Whimbey E. Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients. Am J Med 1997; 102: 61-70
101. Feldman RJ, Fidalgo HC, John Jr JF. Respiratory syncytial virus in a cardiac surgery intensive care unit [letter]. J Thorac Cardiovasc Surg 1994; 108: 1152
102. Takimoto CH, Cram DL, Root RK. Respiratory syncytial virus infections on an adult medical ward. Arch Intern Med 1991; 151: 706-8
103. Whimbey E, Champlin RE, Englund JA, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16: 393-9
104. Liss HP, Bernstein J. Ribavirin aerosol in the elderly. Chest 1988; 93: 1239-41
105. Englund JA, Piedra P, Jefferson LS, et al. High-dose, short duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection. J Pediatr 1990; 117: 313-20
106. Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992; 165: 987-93
107. Hertz MI, Englund JA, Snover D, et al. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine (Baltimore) 1989; 68: 269-81
108. Hall CB, Douglas RG, Geiman JM. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 1980; 141: 98-102
109. Hall CB, Douglas Jr RG. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99: 100-3
110. Rechsteiner J, Winkler KC. Inactivation of respiratory syncytial virus in aerosol. J Gen Virol 1969; 5: 405-10
111. Madge P, Paton JY, McColl JH, et al. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992; 340: 1079-83
112. Graman PS, Hall CB. Epidemiology and control of nosocomial viral infections. Infect Dis Clin N Am 1989; 3: 815-41
113. Falsey AR, Criddle MM, Kolassa JE, et al. Evaluation of a handwashing intervention to reduce respiratory illness rates in senior day-care centers. Infect Control Hosp Epidemiol 1999; 20: 200-2
114. Walsh EE, Falsey AR. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. J Infect Dis 2004; 190: 373-8
115. Falsey AR, Walsh EE. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine [PFP-2] in ambulatory adults over age 60. Vaccine 1996; 14: 1214-8
116. Falsey AR, Walsh EE. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine [PFP-2] in the institutionalized elderly. Vaccine 1997; 15: 1130-2
117. Gonzalez IM, Karron RA, Eichelberger M, et al. Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine [PFP-2] in healthy young and older adults. Vaccine 2000; 18: 1763-72